Hemerion Therapeutics

Villeneuve-d'Ascq, France · Founded 2020 · Privately Held (backing)

Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. Hemerion Therapeutics is based in Villeneuve-d'Ascq, France and was founded in 2020. Its last reported valuation was $26.2 million in May 2025. It has raised $14.2 million.

Last reported valuation

$26.2M

Oct 2026

Priced at

—

Total raised

$14.2M

Last round

—

How much has Hemerion Therapeutics raised?

$14.2Macross 0 recorded rounds

Free account

More of Hemerion Therapeutics with a free account

·Watch Hemerion Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Hemerion Therapeutics investors

9 investors are on record for Hemerion Therapeutics, including Bpifrance, France 2030, Finorpa and Finovam Gestion.

For fundraisers

Raising for a company like Hemerion Therapeutics?

9 investors have backed Hemerion Therapeutics.

See all 9 investors →

Frequently asked about Hemerion Therapeutics

How much has Hemerion Therapeutics raised?: Hemerion Therapeutics has raised $14.2M in total across 0 recorded funding rounds.